Managers / Q4 2022 · view latest →
Unconventional Investor, LLC
CIK 0001910387 · 162 MILL POND WAY, UNIT 2, PORTSMOUTH, NH, 03801 · (415) 235-3729
Summary
Unconventional Investor, LLC reported $99M in U.S.-listed holdings across 30 positions for Q4 2022.
The portfolio is heavily concentrated: Total Stock Market Etf alone accounts for 32.0% of reported value.
Compared with Q3 2022, the fund opened 2 new positions and exited 3.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 77.9% · $77M
- Common Stock · 18.6% · $18M
- Other · 3.5% · $3M
Quarter-over-Quarter Changes full breakdown →
vs Q3 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| VANGUARD FTSE EUROPE ETF | NEW | +17.6K | 17.6K | +$978,166 | $978,166 |
| VVisa International | NEW | +1.0K | 1.0K | +$215,045 | $215,045 |
| Vanguard S&P 500 ETF | ADDED | +21.0K | 25.8K | +$7M | $9M |
| VANGUARD FTSE EMERGING MARKETS ETF | SOLD OUT | −23.3K | 0 | −$849,000 | $0 |
| FIRST TRUST CLOUD COMPUTING ETF | SOLD OUT | −3.5K | 0 | −$211,000 | $0 |
| OSCROSCAR HEALTH INC | SOLD OUT | −15.8K | 0 | −$79,000 | $0 |
| Vanguard Int'l Equity Index ETF | TRIMMED | −23.5K | 43.6K | −$790,418 | $2M |
| Total Stock Market ETF | TRIMMED | −35.3K | 165.2K | −$4M | $32M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2022
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $211M | 46 | May 18, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $211M | 47 | Feb 5, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $199M | 45 | Nov 7, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $181M | 40 | Aug 1, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $169M | 34 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $166M | 35 | Feb 19, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $160M | 34 | Nov 18, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $142M | 33 | Aug 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $139M | 33 | May 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $126M | 32 | Feb 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $114M | 33 | Nov 16, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $110M | 32 | Aug 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $105M | 33 | May 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $99M | 30 | Feb 6, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $92M | 31 | Oct 24, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $97M | 33 | Jul 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $109M | 33 | Apr 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $101M | 34 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.